Kisspeptin-10 · Research brief

Kisspeptin 5mg Reconstitution: Lab Storage and Handling

Real Peptides Research TeamEditorial

Updated September 9, 20269 min read

51 WORDS

Short answer

Most Kisspeptin-10 that underperforms in an assay was never damaged by the assay. It was damaged somewhere between the courier's van and the freezer shelf. Peptide degradation is quiet: it doesn't change the label, it rarely changes the look of the powder, and no benchtop check will recover the data afterwards.

Key takeaways

Kisspeptin-10 is the C-terminal decapeptide of the KISS1 gene product and the endogenous agonist at KISS1R (GPR54), and its C-terminal amide is both essential to receptor activity and a hydrolysis target.
A vial labelled 5mg holds 5mg of gross lyophilized material, so concentration maths for kisspeptin 5mg reconstitution should use the net peptide content printed on that lot's certificate of analysis.
Lyophilized peptide is typically stored at -20°C or colder and desiccated, while reconstituted stock is typically refrigerated at 2-8°C or frozen in single-use aliquots.
Allowing a frozen vial to reach room temperature before opening prevents condensation from seeding hydrolysis in a cake that hasn't touched solvent yet.
Frost-free freezers run automatic defrost cycles that push the chamber above setpoint, which makes manual-defrost units the safer home for peptide aliquots.
Cloudiness, fibrils or yellowing indicate aggregation or oxidation, and neither is reversed by centrifugation or filtration.

Our team synthesises and lot-verifies peptides in small batches, and the pattern is consistent. Researchers ask detailed questions about assay buffers and almost nothing about what happens during the kisspeptin 5mg reconstitution step. That order of priorities is backwards.

How is kisspeptin 5mg reconstitution handled in a research laboratory?

Kisspeptin 5mg reconstitution is the process of dissolving a 5mg lyophilized vial of Kisspeptin-10 in a sterile laboratory solvent to produce a defined stock concentration. Lyophilized peptide is typically held at -20°C or colder; once in solution it is generally aliquoted, refrigerated at 2-8°C for near-term use, and protected from repeated freeze-thaw.

One assumption sinks more concentration calculations than any other: that a vial labelled 5mg contains 5mg of peptide. It contains 5mg of gross lyophilized material, which includes trifluoroacetate counterions and residual water, so net peptide content is lower and is stated on the certificate of analysis for that batch. What follows covers what solvent contact does chemically, how refrigeration and freeze-thaw actually affect stability, and how to read the lot label and COA before the first kisspeptin 5mg reconstitution.

What solvent contact does to the lyophilized cake

Kisspeptin-10, also called metastin 45-54, is the C-terminal decapeptide of the KISS1 gene product and the endogenous agonist at KISS1R (formerly GPR54), a G protein-coupled receptor. Its sequence is Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe with a C-terminal amide, and that terminal amide is the part worth worrying about. Hydrolysis of the amide shifts the mass by roughly one dalton while costing much of the receptor binding, which means degraded material can look almost normal on a crude mass check and behave like a different compound in the assay.

Freeze-drying works because it removes the water that hydrolysis needs. Reconstitution puts the water back. From the moment solvent touches the cake, three clocks start: hydrolysis at the C-terminal amide and at asparagine residues (deamidation), oxidation of the tryptophan indole ring, and physical aggregation at the air-liquid interface.

Technique matters more here than most guides admit. Solvent should run down the inner wall of the vial rather than land directly on the cake, and the vial should be rolled or swirled, never shaken. Vigorous shaking drives peptide to the air-liquid interface, where partial unfolding seeds aggregates that never redissolve. Sterile water, bacteriostatic water and dilute acetic acid are all used as laboratory solvents depending on solubility and downstream compatibility, and the pH chosen at the kisspeptin 5mg reconstitution stage carries forward into every dilution made from that stock.

In our experience, the errors that ruin a lot happen in the first two minutes of handling, not over weeks of storage.

Laboratory preparation tool

The easiest way to get reconstitution right: enter what's in the vial and how much bacteriostatic water you're adding, and get the exact concentration and measured volumes for your lab work.

One thing to understand before you calculate: this tool — and everything we sell — is for education and laboratory research. Researchers and labs use it to prepare and document research solutions. It isn't medical advice or dosing guidance, and nothing here is for human or veterinary consumption. Full details in our Terms of Service.

Vial contentsmgBacteriostatic water addedmLQuantity of material to measuremgOptional

Everything this calculator returns describes a solution on a lab bench: milligrams of material, milliliters of solvent, the concentration that results. That's by design — it's an educational tool for researchers, and it offers no guidance about administering anything to anyone. What you do in your lab is governed by your institution's protocols and applicable law.

Open the full peptide calculator →

Refrigeration, freezing, and the freeze-thaw problem

Cold slows chemistry, but temperature alone isn't the whole storage picture. Lyophilized research peptides are typically stored at -20°C, with -80°C used for extended holding, kept desiccated, sealed and shielded from light. Tryptophan and tyrosine both absorb in the near-UV, so amber vials or foil wrapping are cheap insurance on a decapeptide that contains one of each.

Here's the detail almost nobody mentions: let a frozen vial equilibrate to room temperature before breaking the seal. A cold vial opened into humid room air pulls condensation straight into a hygroscopic cake, and that moisture is enough to start hydrolysis on material that hasn't been reconstituted yet. Some of the most degraded lots we've been asked to look at were never technically in solution at all. They were opened cold, repeatedly.

Freeze-thaw does the rest of the damage. Each cycle concentrates solute in the shrinking liquid phase as ice forms, and in sodium phosphate systems freezing can shift pH sharply as the dibasic salt crystallizes first, exposing the peptide to conditions it never sees at bench temperature. Single-use aliquots solve this. So does avoiding frost-free freezers, which run automatic defrost cycles that lift the chamber above setpoint on a schedule. A manual-defrost unit is the correct home for anything stored after kisspeptin 5mg reconstitution.

Refrigerated stock at 2-8°C is best treated as a short working window measured in days to a few weeks, with frozen aliquots for anything longer.

Reading the lot label, the COA, and any change in appearance

The label tells you three useful things: the compound, the gross fill weight, and the lot number. Everything analytically meaningful lives with the lot. A certificate of analysis for that specific batch should report identity by mass spectrometry against the theoretical mass, purity by reverse-phase HPLC as area percent at 214 to 220 nm, and net peptide content, which is what the concentration maths for kisspeptin 5mg reconstitution should actually be based on.

Appearance is a coarse signal, but a real one. A normal lyophilized cake is white to off-white, either fluffy or a compact disc. A cake that looks collapsed, melted or shrunken against the glass suggests time spent above the formulation's glass transition temperature in transit. Yellowing points toward oxidation. Once solvent is added, the solution should be clear and colourless; haze, visible fibrils or a persistent film indicates aggregation, and spinning it out doesn't restore what has already dropped out of solution.

So why do so many labs check the paperwork only after a strange result? Match the lot number on the vial to the published document first. Every batch shipped by Real Peptides is small-batch synthesised with exact amino-acid sequencing and a lot-matched certificate of analysis.

Kisspeptin-10 is supplied for laboratory research only and is not for human or veterinary consumption; anyone with a question about an animal's health should talk to their veterinarian rather than a peptide supplier. This article is educational and describes general peptide-chemistry practice, not a protocol for any living subject.

Kisspeptin 5mg Reconstitution: Solvent and Storage Comparison

The table sets out the conditions commonly applied to lyophilized research peptides at each handling stage and the specific failure mode each condition guards against. Treat these as general peptide-chemistry conventions rather than compound-specific stability data for Kisspeptin-10.

Handling stage	Typical storage condition	Typical working window	Dominant degradation risk	Bottom line for the lab
Sealed lyophilized vial, long term	-20°C or colder, desiccated, protected from light	Months, per supplier guidance for the lot	Moisture ingress and slow oxidation	Coldest, driest, darkest wins; this is the cheapest stability a lab will ever buy
Lyophilized vial, bench or transit	Ambient, short duration only	Hours to a few days	Condensation and repeated thermal cycling	Brief ambient exposure of dry material is normal; repeated warm-cold cycling is not
Reconstituted stock, refrigerated	2-8°C, sealed, shielded from light	Days to a few weeks	Hydrolysis of the C-terminal amide and deamidation	Fine for active work, poor as a storage strategy
Reconstituted stock, frozen aliquots	-20°C to -80°C in single-use volumes	Longest option available after solvent contact	Aggregation from repeated freeze-thaw and cryoconcentration	Aliquot at the moment of kisspeptin 5mg reconstitution, never later
Working dilution in buffer at bench	Room temperature during the session	Same session only	Surface adsorption and air-liquid interface aggregation	Make it fresh, use it fast, and check carrier protein compatibility

What If: Kisspeptin Handling Scenarios

What if the vial arrives at ambient temperature after shipping?

Inspect the cake and confirm the lot against its certificate of analysis before doing anything else. Lyophilized peptides are far more thermally robust than solutions, and shipping dry material at ambient temperature is standard practice across the industry. A cake that's still white, dry and intact is the reassuring outcome; collapse, discolouration or a syrupy film on the glass is the reason to stop and contact the supplier rather than proceed.

What if the reconstituted solution turns cloudy after a few days at 2-8°C?

Treat it as aggregated and pull it from quantitative work. Cloudiness after kisspeptin 5mg reconstitution usually reflects peptide coming out of solution rather than microbial contamination, often driven by pH drift, concentration above practical solubility, or interface stress from earlier agitation. Filtering clears the visible particles but removes peptide with them, so the calculated concentration no longer matches what's in the tube.

What if there's no visible powder in the vial?

Proceed as planned. A 5mg fill of a decapeptide can lyophilize to a nearly invisible film on the vial wall or base, and transit vibration frequently breaks a cake into powder that settles out of sight. The absence of a fluffy plug isn't evidence of an empty vial. Add solvent down the wall, roll gently, and confirm full dissolution against a dark background before use.

What if aliquots have been through several freeze-thaw cycles?

Assume some loss of active material and requalify before comparing against earlier data. Each cycle adds cryoconcentration stress and another opportunity for interface aggregation, and those losses accumulate unevenly across tubes from the same stock. If a dataset spans multiple thaws, freeze-thaw count belongs in the notes as a recorded variable, not an unlogged assumption.

What if the lot number on the vial doesn't match the published COA?

Query it with the supplier before any solvent goes in. A certificate of analysis is only meaningful for the batch it was generated from, because purity, net peptide content and residual solvent all vary between synthesis runs. Borrowing a neighbouring lot's document means the stated molarity is an estimate taken from different material.

The Blunt Truth About Shelf-Life Numbers on Peptide Vials

Let's be direct about this: nobody can give a universal expiry date for reconstituted Kisspeptin-10, and any source stating one with confidence is quoting convention, not compound-specific data. Solution-phase stability depends on solvent, pH, concentration, container material, light exposure and how many times the septum has been pierced. The 28-day figure that circulates online comes from preservative-efficacy conventions in clinical pharmacy, not from stability studies on this peptide. The defensible approach after kisspeptin 5mg reconstitution is to aliquot, freeze, date every tube, and treat time in solution as a variable you record.

Good kisspeptin 5mg reconstitution practice is really an admission that the vial is the least controlled part of most experiments. Everything downstream gets replicated, blinded and tested for significance, while the material itself gets whatever handling the day allowed. Peptides don't fail loudly. They drift, shed a fraction of their activity, and hand back a result that reads like biology when it's actually chemistry that happened in a warm delivery van. Date the aliquots. Log the thaw count. The freezer is part of the method, whether or not it appears in the write-up.

References

Peer-reviewed sources on Kisspeptin-10 indexed in PubMed, listed for research context. Real Peptides supplies Kisspeptin-10 for laboratory research use only.

Kisspeptin-10 protects against HIV-1 Tat-induced blood-brain barrier dysfunction and neuroinflammation via RhoA/ROCK pathway: Implications for HAND therapy. Neurotoxicology, 2025. PMID 40712838. doi:10.1016/j.neuro.2025.07.008
Adult Neurogenesis Is Regulated by the Endocannabinoid and Kisspeptin Systems. International journal of molecular sciences, 2025. PMID 40362219. doi:10.3390/ijms26093977
Kisspeptin-10 Protects Against TNF-α-Induced Chondrocyte Senescence via the SIRT1/p53/p21 Signaling. Journal of biochemical and molecular toxicology, 2025. PMID 40400312. doi:10.1002/jbt.70298
Effects of kisspeptin on the maturation of human ovarian primordial follicles in vitro. Zygote (Cambridge, England), 2024. PMID 38099429. doi:10.1017/S0967199423000527
Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src. Nature communications, 2024. PMID 38346942. doi:10.1038/s41467-024-44852-9
Kisspeptin Regulates Cell Invasion and Migration in Endometrial Cancer. Journal of the Endocrine Society, 2024. PMID 38264268. doi:10.1210/jendso/bvae001
Kisspeptin and Endometriosis-Is There a Link?. Journal of clinical medicine, 2024. PMID 39768606. doi:10.3390/jcm13247683
Kisspeptin neuron projections to oxytocin neurons are not necessary for parturition in the mouse. Brain structure & function, 2023. PMID 37389617. doi:10.1007/s00429-023-02670-7

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

A 5mg lyophilized vial of Kisspeptin-10 is brought to room temperature, then a measured volume of sterile laboratory solvent is added slowly down the inner wall of the vial rather than directly onto the cake. The vial is rolled or swirled until the solution is clear, never shaken, because agitation drives aggregation at the air-liquid interface. The resulting stock is then aliquoted into single-use volumes before storage.

The three most common failures are shaking the vial, which seeds irreversible aggregates at the air-liquid interface, opening a cold vial into humid room air so condensation enters the hygroscopic cake, and calculating concentration from the 5mg label weight instead of the net peptide content on the certificate of analysis. All three produce a stock that is either less concentrated or less active than the record says it is.

There is no universal figure, because solution-phase stability depends on solvent, pH, concentration, container and light exposure. Refrigerated stock at 2-8°C is generally treated as a short working window of days to a few weeks in laboratory practice, with frozen single-use aliquots used for anything longer. Recording the reconstitution date on every tube is more useful than relying on a generic shelf-life number.

Neither is universally better; the choice depends on solubility, downstream assay compatibility and how long the stock will be accessed. Bacteriostatic water contains benzyl alcohol as a preservative, which suits multi-draw laboratory stocks but can interfere with some cell-based work. Sterile water and dilute acetic acid are common where a clean matrix matters or where a peptide dissolves poorly at neutral pH.

It can be, but each freeze-thaw cycle adds cumulative damage through cryoconcentration and interface aggregation, and the losses are rarely uniform across tubes. This is why single-use aliquots prepared at the point of reconstitution are the standard laboratory approach. If refreezing is unavoidable, the thaw count should be logged as an experimental variable.

Net peptide content is the proportion of the gross fill weight that is actually peptide, with the remainder made up of counterions such as trifluoroacetate, residual water and bound solvent. A vial labelled 5mg therefore delivers less than 5mg of peptide. Concentration calculations based on the label weight rather than net content will overstate molarity, sometimes substantially.

The C-terminal amide is required for activity at KISS1R, the receptor formerly known as GPR54. Hydrolysis of that amide during storage in solution changes the molecular mass by roughly one dalton, which is easy to miss on a crude mass check, while removing much of the receptor binding. That is the core reason dry storage at -20°C or colder is preferred over holding material in solution.

Yes. The sequence contains both tryptophan and tyrosine, which absorb in the near-UV range and are susceptible to photo-oxidation. Amber vials, foil wrapping or simply storing the vial inside an opaque box are all adequate, and cost effectively nothing relative to the value of the material.

Pricing varies widely between suppliers depending on purity specification, synthesis scale and batch documentation, so quoted figures are only comparable when the analytical paperwork is comparable. What should be included at any price point is a lot-matched certificate of analysis showing identity by mass spectrometry, purity by reverse-phase HPLC and net peptide content. A cheap vial without lot-matched documentation is not a cheap vial.

Kisspeptin-10 is supplied strictly for laboratory research use and is not an approved drug product for human or veterinary consumption. It is intended for qualified researchers and institutions conducting in vitro or preclinical work. Anyone with a health question concerning a person or an animal should speak with a physician or a veterinarian rather than a peptide supplier.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA